Rule 26 Information

One of the UK's leading commercial stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities. The strategy is to:

Build a profitable and cash generative business

Develop and commercialise low development-risk late-stage products for unmet medical needs in the US